Glycemic Profiles of Healthy Individuals with Low Fasting Plasma Glucose and HbA1c

Overview

Journal ISRN Endocrinol

Specialty Endocrinology

Date 2012 Feb 25

PMID 22363877

Citations 7

Authors

Kyoko Nomura

Tomoyuki Saitoh

Gwang U Kim

Toshikazu Yamanouchi

Affiliations

Soon will be listed here.

Abstract

Scant data exists on glucose profile variability in healthy individuals. Twenty-nine healthy subjects without diabetes (86% male; mean age, 38 years) were measured by a CGM system and under real-life conditions. The median percentage of time spent on the blood glucose >7.8 mmol/L for 24 hrs was greater than 10% in both NFG and IFG groups. When subjects were divided into either NFG group (i.e., FPG levels of <5.6 mmol/L; n = 22) or IFG group (FPG levels of 5.6-6.9 mmol/L; n = 7), all CGM indicators investigated but GRADE scores, including glucose variability measures, monitoring excursions, hyperglycemia, hypoglycemia, and 24-hour AUC, did not differ significantly between the two groups. GRADE score and its euglycemia% were significantly different between the two groups. Among various CGM indicators, GRADE score may be a sensitive indicator to discriminate glucose profiles between subjects with NFG and those with IFG.

Citing Articles

Early detection of type 2 diabetes risk: limitations of current diagnostic criteria.

Zhang J, Zhang Z, Zhang K, Ge X, Sun R, Zhai X Front Endocrinol (Lausanne). 2023; 14:1260623.

PMID: 38027114 PMC: 10665905. DOI: 10.3389/fendo.2023.1260623.

Time above range for predicting the development of type 2 diabetes.

Marco A, Pazos-Couselo M, Moreno-Fernandez J, Diez-Fernandez A, Alonso-Sampedro M, Fernandez-Merino C Front Public Health. 2022; 10:1005513.

PMID: 36568777 PMC: 9772988. DOI: 10.3389/fpubh.2022.1005513.

Continuous glucose monitoring metrics for earlier identification of pre-diabetes: protocol for a systematic review and meta-analysis.

Gottfried S, Pontiggia L, Newberg A, Laynor G, Monti D BMJ Open. 2022; 12(8):e061756.

PMID: 36008066 PMC: 9422846. DOI: 10.1136/bmjopen-2022-061756.

Postprandial glycemic response in a non-diabetic adult population: the effect of nutrients is different between men and women.

Gonzalez-Rodriguez M, Pazos-Couselo M, Garcia-Lopez J, Rodriguez-Segade S, Rodriguez-Garcia J, Tunez-Bastida C Nutr Metab (Lond). 2019; 16:46.

PMID: 31346341 PMC: 6637571. DOI: 10.1186/s12986-019-0368-1.

Glucotypes reveal new patterns of glucose dysregulation.

Hall H, Perelman D, Breschi A, Limcaoco P, Kellogg R, McLaughlin T PLoS Biol. 2018; 16(7):e2005143.

PMID: 30040822 PMC: 6057684. DOI: 10.1371/journal.pbio.2005143.

References

Zhou J, Jia W, Yu M, Yu H, Bao Y, Ma X . [The reference values of glycemic parameters for continuous glucose monitoring and its clinical application]. Zhonghua Nei Ke Za Zhi. 2007; 46(3):189-92. View

. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Diabetologia. 1999; 42(6):647-54. DOI: 10.1007/s001250051211. View

Hill N, Hindmarsh P, Stevens R, Stratton I, Levy J, Matthews D . A method for assessing quality of control from glucose profiles. Diabet Med. 2007; 24(7):753-8. DOI: 10.1111/j.1464-5491.2007.02119.x. View

. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001; 161(3):397-405. DOI: 10.1001/archinte.161.3.397. View

Rodbard D . Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009; 11 Suppl 1:S55-67. DOI: 10.1089/dia.2008.0132. View

Borg R, Kuenen J, Carstensen B, Zheng H, Nathan D, Heine R . Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study. Diabetologia. 2010; 53(8):1608-11. PMC: 2892065. DOI: 10.1007/s00125-010-1741-9. View

Makris K, Spanou L, Rambaouni-Antoneli A, Koniari K, Drakopoulos I, Rizos D . Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients. Diabet Med. 2008; 25(2):174-8. DOI: 10.1111/j.1464-5491.2007.02379.x. View

Ning F, Tuomilehto J, Pyorala K, Onat A, Soderberg S, Qiao Q . Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range. Diabetes Care. 2010; 33(10):2211-6. PMC: 2945162. DOI: 10.2337/dc09-2328. View

Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T . Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med. 2005; 353(14):1454-62. DOI: 10.1056/NEJMoa050080. View

10.

Kovatchev B, Clarke W, Breton M, Brayman K, McCall A . Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabetes Technol Ther. 2006; 7(6):849-62. DOI: 10.1089/dia.2005.7.849. View

11.

Kovatchev B, Cox D, Kumar A, Gonder-Frederick L, Clarke W . Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Diabetes Technol Ther. 2003; 5(5):817-28. DOI: 10.1089/152091503322527021. View

12.

Kishimoto M, Yamasaki Y, Kubota M, Arai K, Morishima T, Kawamori R . 1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM. Diabetes Care. 1995; 18(8):1156-9. DOI: 10.2337/diacare.18.8.1156. View

13.

Kovatchev B, Otto E, Cox D, Gonder-Frederick L, Clarke W . Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care. 2006; 29(11):2433-8. DOI: 10.2337/dc06-1085. View

14.

Matthews J, Altman D, Campbell M, Royston P . Analysis of serial measurements in medical research. BMJ. 1990; 300(6719):230-5. PMC: 1662068. DOI: 10.1136/bmj.300.6719.230. View

15.

Zhou J, Li H, Ran X, Yang W, Li Q, Peng Y . Reference values for continuous glucose monitoring in Chinese subjects. Diabetes Care. 2009; 32(7):1188-93. PMC: 2699703. DOI: 10.2337/dc09-0076. View

16.

SCHLICHTKRULL J, Munck O, JERSILD M . THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS. Acta Med Scand. 1965; 177:95-102. DOI: 10.1111/j.0954-6820.1965.tb01810.x. View

17.

Mazze R, Strock E, Wesley D, Borgman S, Morgan B, Bergenstal R . Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther. 2008; 10(3):149-59. DOI: 10.1089/dia.2007.0293. View

18.

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011; 34 Suppl 1:S62-9. PMC: 3006051. DOI: 10.2337/dc11-S062. View

19.

Kovatchev B, Gonder-Frederick L, Cox D, Clarke W . Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care. 2004; 27(8):1922-8. DOI: 10.2337/diacare.27.8.1922. View

20.

Yamanouchi T, Moromizato H, Shinohara T, MINODA S, Miyashita H, Akaoka I . Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol. Metabolism. 1992; 41(8):862-7. DOI: 10.1016/0026-0495(92)90168-a. View